About this document
Cangrelor Use in Coronary Intervention by Mohammed Ali is a document available to read on EtoBox.
NICE has not made a recommendation for the use of cangrelor in reducing atherothrombotic events during percutaneous coronary intervention or surgery due to insufficient evidence from The Medicines Company. NHS organizations are advised to follow local decision-making guidelines in the absence of NICE guidance. The situation may be reassessed if the company submits the necessary evidence.
- Author
- Mohammed Ali
- Language
- EN